Marzia Campanile

Marzia Campanile

Auto-generated profile, based on publicly available information

Marzia Campanile

Department of Chemistry, Materials and Chemical Engineering ‘Giulio Natta,’ Politecnico di Milano 1 , Milan, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2023 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
FDFrancesca Donnaloja
Francesca Donnaloja
LILuca Izzo
Luca Izzo
MCMarzia Campanile
Marzia Campanile
SPSimone Perottoni
Simone Perottoni
LBLucia Boeri
Lucia Boeri
DADiego Albani
Diego Albani
We developed an innovative millifluidic organ-on-a-chip device, named MINERVA 2.0, that is optically accessible and suitable to serial connection. In the present work, we evaluated MINERVA 2.0 as millifluidic gut epithelium-on-a-chip by using computational modeling and biological assessment. We also tested MINERVA 2.0 in a serially connected configuration prodromal to address the complexity of multiorgan interaction. Once cultured under perfusion in our device, human gut immortalized Caco-2 epithelial cells were able to survive at least up to 7 days and form a three-dimensional layer with detectable tight junctions (occludin and zonulin-1 positive). Functional layer development was supported by measurable trans-epithelial resistance and FITC-dextran permeability regulation, together with mucin-2 expression. The dynamic culturing led to a specific transcriptomic profile, assessed by RNASeq, with a total of 524 dysregulated transcripts (191 upregulated and 333 downregulated) between static and dynamic condition. Overall, the collected results suggest that our gut-on-a-chip millifluidic model displays key gut epithelium features and, thanks to its modular design, may be the basis to build a customizable multiorgan-on-a-chip platform.

17 October 2026 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MPMaria Teresa Palano
Maria Teresa Palano
FRFederica Riccio
Federica Riccio
LSLuisa Sambado
Luisa Sambado
ETElena Tagliabue
Elena Tagliabue
MBMilena Bertolotti
Milena Bertolotti
Gaia SpinettiGaia Spinetti
Gaia Spinetti
Patients with type 2 diabetes mellitus (T2DM) and critical limb‐threatening ischemia (CLTI), a severe vascular complication associated with amputation and high mortality, exhibit chronic inflammation and endothelial dysfunction. We previously reported an increased frequency of natural killer (NK) cells in advanced CLTI; however, whether NK cell alterations are already present in patients with peripheral neuropathy, which often precedes diabetic foot lesions with or without distal macroangiopathy, remains unclear. We conducted an observational pilot study to assess circulating NK cell frequency by flow cytometry and inflammatory plasma cytokines profiling by ELISA in 177 subjects stratified into five groups: healthy controls (HC, n = 25); T2DM without neurovascular complications (D, n = 26); non‐macrovascular neuropathic T2DM without foot lesions (N, n = 40); non‐macrovascular neuropathic T2DM with lower‐limb ulcers/lesions/osteomyelitis (N1, n = 42); and macrovascular revascularized neuropathic T2DM with ulcers/lesions/osteomyelitis (NV, n = 44). NK cell subset frequencies were evaluated in an independent cohort of patients with non‐macrovascular neuropathic T2DM ( n = 22) and healthy controls ( n = 23). NKs were further characterized for degranulation capacity, secretome composition, and pro‐angiogenic activity in vitro and in vivo ( Hirudo verbana ). NK cell frequency was significantly increased in patients with non‐macrovascular neuropathic T2DM compared with controls and was accompanied by elevated plasma levels of soluble mediators associated with NK cell activation and function, including TNF‐α, IL‐12p70, MCP‐1, and IL‐4. NKs from these patients exhibited impaired degranulation and reduced angiogenic capacity in vitro and in vivo. Their secretome is characterized by decreased release of pro‐angiogenic factors and increased secretion of mediators involved in monocyte/macrophage recruitment, resulting in enhanced macrophage recruitment in vivo. If confirmed in larger cohorts, higher frequency and functional impairment of circulating NKs may act as novel therapeutic targets and prognostic biomarkers in peripheral vascular complications of T2DM.